The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2011
Filed:
Mar. 19, 2004
Gregory M. Landes, The Woodlands, TX (US);
Francine Chen, San Francisco, CA (US);
Binyam Bezabeh, Oakland, CA (US);
Ian Foltz, Burnaby, CA;
Kam Fai Tse, Clinton, CT (US);
Michael Jeffers, Branford, CT (US);
Mehdi Mesri, Branford, CT (US);
Gary Starling, Clinton, CT (US);
Peter Mezes, Old Lyme, CT (US);
Nikolia Khramtsov, Branford, CT (US);
Gregory M. Landes, The Woodlands, TX (US);
Francine Chen, San Francisco, CA (US);
Binyam Bezabeh, Oakland, CA (US);
Ian Foltz, Burnaby, CA;
Kam Fai Tse, Clinton, CT (US);
Michael Jeffers, Branford, CT (US);
Mehdi Mesri, Branford, CT (US);
Gary Starling, Clinton, CT (US);
Peter Mezes, Old Lyme, CT (US);
Nikolia Khramtsov, Branford, CT (US);
Curagen Corporation, New Haven, CT (US);
Abstract
The invention described herein is related to antibodies directed to the antigen TIM-1 and uses of such antibodies. In particular, there are provided fully human monoclonal antibodies directed to the antigen TIM-1. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.